Peter R Sinnaeve1, Uwe Zeymer2, Héctor Bueno3, Nicolas Danchin4, Jesús Medina5, Joaquín Sánchez-Covisa6, Muriel Licour7, Lieven Annemans8, J Wouter Jukema9, Stuart Pocock10, Robert F Storey11, Frans Van de Werf12. 1. University Hospitals Leuven, Belgium peter.sinnaeve@uzleuven.be. 2. Institut für Herzinfarktforschung Ludwigshafen, Germany. 3. Hospital General Universitario Gregorio Marañón, Madrid, Spain. 4. Hôpital Européen Georges Pompidou and René Descartes University, Paris, France. 5. Medical Evidence Centre AstraZeneca, Madrid, Spain. 6. Medical Department, AstraZeneca Farmacéutica Spain, Madrid, Spain. 7. Medical Department, AstraZeneca France, Rueil-Malmaison, France. 8. I-CHER (Interuniversity Centre for Health Economics Research) UGent, VUB, Belgium. 9. Leiden University Medical Centre, The Netherlands. 10. London School of Hygiene and Tropical Medicine, UK. 11. University of Sheffield, UK. 12. University Hospitals Leuven, Belgium.
Authors: Yong Huo; Frans Van de Werf; Yaling Han; Xavier Rossello; Stuart J Pocock; Chee Tang Chin; Stephen W-L Lee; Yi Li; Jie Jiang; Ana Maria Vega; Jesús Medina; Héctor Bueno Journal: Am J Cardiovasc Drugs Date: 2021-02-04 Impact factor: 3.571
Authors: Lieven Annemans; Nicolas Danchin; Frans Van de Werf; Stuart Pocock; Muriel Licour; Jesús Medina; Héctor Bueno Journal: Open Heart Date: 2016-02-24
Authors: Aet Saar; Toomas Marandi; Tiia Ainla; Krista Fischer; Mai Blöndal; Jaan Eha Journal: BMC Cardiovasc Disord Date: 2015-10-26 Impact factor: 2.298
Authors: Stuart Pocock; Héctor Bueno; Muriel Licour; Jesús Medina; Lin Zhang; Lieven Annemans; Nicholas Danchin; Yong Huo; Frans Van de Werf Journal: Eur Heart J Acute Cardiovasc Care Date: 2014-10-09